Episodios

  • US Burden of Disorders Affecting the Nervous System
    Nov 24 2025

    Interview with John P. Ney, MD, MPH, author of US Burden of Disorders Affecting the Nervous System: From the Global Burden of Disease 2021 Study. Hosted by Cynthia E. Armand, MD.

    Related Content:

    • US Burden of Disorders Affecting the Nervous System
    Más Menos
    24 m
  • Hemorrhage and Risk Factors in Unruptured Brain AVM
    Oct 6 2025

    Interview with Helen Kim, PhD, author of Risk of Future Hemorrhage From Unruptured Brain Arteriovenous Malformations: The Multicenter Arteriovenous Malformation Research Study (MARS). Hosted by Cynthia E. Armand, MD.

    Related Content:

    • Risk of Future Hemorrhage From Unruptured Brain Arteriovenous Malformations
    Más Menos
    17 m
  • Intravenous Argatroban or Eptifibatide and Mechanical Thrombectomy
    Aug 18 2025

    Interview with Colin P. Derdeyn, MD, author of Intravenous Argatroban or Eptifibatide in Patients Undergoing Mechanical Thrombectomy: A Subgroup Analysis of the MOST Randomized Clinical Trial. Hosted by Cynthia E. Armand, MD.

    Related Content:

    • Intravenous Argatroban or Eptifibatide in Patients Undergoing Mechanical Thrombectomy
    Más Menos
    19 m
  • GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension
    Jul 14 2025

    Interview with Dennis J. Rivet II, MD, author of GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension. Hosted by Cynthia E. Armand, MD.

    Related Content:

    • GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension
    Más Menos
    22 m
  • Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome
    Jun 2 2025

    Interview with Manuel Comabella, MD, author of Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome. Hosted by Cynthia E. Armand, MD.

    Related Content:

    • Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome
    Más Menos
    14 m
  • Fremanezumab for the Treatment of Migraine and Major Depressive Disorder
    May 5 2025

    Interview with Richard B. Lipton, MD, author of Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder. Hosted by Cynthia E. Armand, MD.

    Related Content:

    • Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder
    Más Menos
    21 m
  • Optimal Delay Time to Initiate Anticoagulation After AF-Associated Ischemic Stroke
    Mar 31 2025

    Interview with Steven J. Warach, MD, PhD, author of Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation: A Pragmatic, Response-Adaptive Randomized Clinical Trial. Hosted by Cynthia E. Armand, MD.

    Related Content:

    • Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation
    Más Menos
    17 m
  • Location and Timing of Recurrent, Nontraumatic Intracerebral Hemorrhage
    Mar 3 2025

    Interview with David J. Seiffge, MD, author of Location and Timing of Recurrent, Nontraumatic Intracerebral Hemorrhage. Hosted by Cynthia E. Armand, MD.

    Related Content:

    • Location and Timing of Recurrent, Nontraumatic Intracerebral Hemorrhage
    Más Menos
    16 m